These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 785839)

  • 21. Serial changes in the coagulation system following clotting factor concentrate infusion.
    Preston FE; Winfield DA; Malia RG; Blackburn EK
    Thromb Diath Haemorrh; 1975 Nov; 34(2):475-82. PubMed ID: 1198408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hemostatic changes in the course of different chronic hepatopathies].
    Ruggiero G; De Biasi R; Lembo N; Giusti G
    Minerva Med; 1975 Feb; 66(13):595-601. PubMed ID: 1113909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Walls WD; Losowsky MS
    Thromb Diath Haemorrh; 1969 Feb; 21(1):134-43. PubMed ID: 5773724
    [No Abstract]   [Full Text] [Related]  

  • 24. Study on coagulation profile of patients with cirrhosis of the liver undergoing elective fibreoptic injection sclerotherapy of oesophageal varices.
    Bernardi M; Palareti G; Pini P; Caletti GC; Brocchi E; Gasbarrini G
    Hepatogastroenterology; 1984 Jun; 31(3):125-8. PubMed ID: 6469201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of C3 and cholinesterase in various diseases of the liver.
    Jorge AD; Sanchez D
    Acta Hepatogastroenterol (Stuttg); 1976 Feb; 23(1):19-25. PubMed ID: 1258598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure.
    Gazzard BG; Lewis ML; Ash G; Rizza CR; Bidwell E; Williams R
    Gut; 1974 Dec; 15(12):993-8. PubMed ID: 4448416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma antithrombin III, alpha 2-plasmin inhibitor and plasminogen activities in cases of various liver diseases.
    Ito K; Niwa M; Kawada T; Tanaka Y
    Tokai J Exp Clin Med; 1986 Nov; 11(5):345-52. PubMed ID: 3672563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin therapy in the case of acute liver cirrhosis.
    Fischer M; Gauss P; Korp W; Nobis H; Schnack B; Weissmann A
    Scand J Gastroenterol Suppl; 1973; 19():135-8. PubMed ID: 4515636
    [No Abstract]   [Full Text] [Related]  

  • 30. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders].
    Fischer M
    Wien Klin Wochenschr; 1983 Feb; 95(3):82-5. PubMed ID: 6858171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
    Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prothrombin (factor II) in hepatic diseases].
    Mannucci PM; Lobina GF; Craveri A; Bragotti R; Cerrini R
    G Clin Med; 1968 Dec; 49(12):1311-25. PubMed ID: 5737500
    [No Abstract]   [Full Text] [Related]  

  • 33. [Monitoring blood coagulation in larger liver operations].
    Groh J; Welte M; Azad SC; Kratzer MA
    Infusionsther Transfusionsmed; 1993 Aug; 20(4):173-9. PubMed ID: 8400798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory assessment of coagulation disorders in liver disease.
    Rock WA
    Clin Lab Med; 1984 Jun; 4(2):419-42. PubMed ID: 6388986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The liver and plasma coagulation factors. Pathophysiology].
    Lasch HG
    Thromb Diath Haemorrh Suppl; 1973; 55():37-75. PubMed ID: 4612866
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative study of hemostatic changes in acute viral hepatitis and terminal cirrhosis].
    Lemberg A; Bengochea L; Pierangeli N
    Acta Gastroenterol Latinoam; 1982; 12(4):371-5. PubMed ID: 7185233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor II related antigen and antithrombin III levels as indicators of liver failure in consumption coagulopathy.
    Sié P; Letrenne E; Caranobe C; Genestal M; Cathala B; Boneu B
    Thromb Haemost; 1982 Jun; 47(3):218-20. PubMed ID: 6810490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal bleeding during surgery.
    Gans H
    Arch Chir Neerl; 1971; 23(1):75-82. PubMed ID: 5579926
    [No Abstract]   [Full Text] [Related]  

  • 40. Relevance of clotting tests in liver disease.
    Thachil J
    Postgrad Med J; 2008 Apr; 84(990):177-81. PubMed ID: 18424573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.